Caricamento...
Understanding the molecular basis of acute myeloid leukemias: where are we now?
Although the treatment modalities for acute myeloid leukemia (AML) have not changed much over the past 40 years, distinct progress has been made in deciphering the basic biology underlying the pathogenesis of this group of hematological disorders. Studies show that AML development is a multicause, m...
Salvato in:
| Pubblicato in: | Int J Hematol Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172002/ https://ncbi.nlm.nih.gov/pubmed/30302223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2017-0002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|